-
-
- Sep 13/26
Weekly reads: suite of reprogramming news, cancer trial reform, zombie retracted papers - Sep 9/26
Cord blood stem cells support off-the-shelf TCR therapy development - Sep 9/26
The real cost of CAR T-cell therapy in myeloma - Sep 8/26
BrainChild Bio moves CAR-T into pivotal study for paediatric brain cancer - Sep 8/26
New review highlights promise of intra-arterial stem cell therapy to improve stroke recovery - Sep 8/26
UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumours - Sep 8/26
Two children died from gene therapies in China: where the field goes next - Sep 8/26
Tiny tumour-triggered patches turn immune cells into cancer fighters - Sep 7/26
Cell and gene therapy sector gains fresh backing as suppliers scale-up capacity - Sep 4/26
Engineering a kinase-controlled allosteric switch for improved performance - Sep 3/26
Typewriter raises $56m Series A to progress non-viral gene therapy platform - Sep 3/26
Ultragenyx’s ‘high-risk’ Angelman bet fails, cratering stock and forcing strategic review - Sep 2/26
Ex-Samsung Biologics executive to co-lead Korea’s MEDIPOST - Sep 1/26
Novartis and BMS slam breaks on gene therapy trials after adverse events - Aug 31/26
This Week’s CGT News: Bristol Myers ends Cellares manufacturing agreement - Aug 31/26
UC San Diego researchers win DARPA award to develop improved red blood cells - Aug 31/26
Why retinal diseases could become the proving ground for the next generation of regenerative therapies - Aug 30/26
Canada needs to bolster its biomanufacturing capacity - Aug 30/26
Weekly reads: aging clocks under the gun, more on R3 Stem warning, Capricor update, FDA perinatal tissue setbackWeekly reads: aging clocks under the gun, more on R3 Stem warning, Capricor update, FDA perinatal tissue setback - Aug 29/26
Engineered Komagataella phaffii boosts full-length human type III collagen production - Aug 28/26
The secret identity of a cell cycle regulator in cells that don’t cycle - Aug 28/26
Study compares BBB-crossing AAV capsids for efficient central nervous system delivery - Aug 27/26
Unexpected discovery reveals mechanism behind brain tumour development - Aug 26/26
Big implications for clinic arena from FDA warning to R3 Stem Cell, David Greene, & associated firms - Aug 25/26
Alpha protein kinase 3 gene therapy restores heart function in cardiomyopathy models - Aug 25/26
First-in-human pilot trial for new sickle cell disease gene therapy approach proves quicker, more efficient than industry average - Aug 25/26
Two decades of induced pluripotent stem cells: From pluripotency to reprogramming - Aug 24/26
New hydrogel platform simplifies the creation of living tissue models - Aug 24/26
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy - Aug 23/26
Weekly reads: Heidi Overton FDA commish nominee, NASA stem cells, aged brain organoids, cautious Nature iPS cell editorial - Aug 20/26
Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa - Aug 20/26
The BioPharm Brief: Rare Disease, New Options - Aug 19/26
3D-printed spheroids support the regeneration of bone tissue - Aug 19/26
Red blood cells inspire next-generation therapeutic nanocarriers - Aug 18/26
Red blood cell-inspired carriers show promise for gene therapy delivery - Aug 18/26
Researchers develop invisible cell armour for safer diabetes treatment - Aug 18/26
Spatial biology in infectious disease and emerging fields - Aug 17/26
After two undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? - Aug 17/26
Dongguk University researchers develop innovative electromagnetically controllable gene switch - Aug 17/26
Red blood ells inspire next-generation nanocarriers for targeted therapies - Aug 17/26
New imaging technology tracks cancer from the whole body to single cells - Aug 17/26
This Week’s CGT News: T-cell therapy clears pediatric solid tumour - Aug 15/26
DUSP4 boosts antitumour CD8+ T cells, CAR-T efficacy in colorectal cancer mice - Aug 14/26
First human trials of designer protein therapies stun US neuroscientists - Aug 14/26
Fate Therapeutics initiates potentially registrational trial of off-the-shelf CAR T-cell therapy FT819 for lupus nephritis - Aug 14/26
A genomics library for the AI era - Aug 14/26
Cell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment - Aug 13/26
Meis2 gene identified as potential therapeutic target for neurodevelopmental disorders - Aug 13/26
Editorial: Can iPS cells clear the barriers to practical use? - Aug 11/26
Lorenz Studer begins Presidency of International Society for Stem Cell Research - Aug 10/26
This Week’s CGT News: In vivo CAR T draws major investment - Aug 10/26
Building scalable, reliable AAV gene therapy manufacturing - Aug 9/26
Weekly reads: DOJ claims $95M perinatal tissue fraud, 6-year peptide prison term, ALS patient story, worrisome MRT clinics - Aug 7/26
Gene therapy may prevent dilated intercellular spaces linked to acid reflux disease - Aug 6/26
Advancements in iPSC technology: Enhancing precision medicine and therapeutics - Aug 6/26
Teaching lab-grown liver cells to grow up: how AI and genetics are transforming stem cell research - Aug 6/26
Prime editing precisely corrects GJB2 c.235delC mutation in laboratory cells - Aug 6/26
Shuttling gene activating proteins through packed histones treats neurodegenerative disease - Aug 5/26
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad - Aug 5/26
How scientists hope to retrain the immune system after an organ transplant - Aug 5/26
Allogeneic immunotherapy harnesses donor cells to fight disease - Aug 5/26
Engineered spinal interneurons show promise for repairing spinal cord injuries - Aug 5/26
Soluble signals released by neighbouring cells direct how the human kidney is built - Aug 5/26
Midweek news: another FDA warning & Florida state stem cell law problems already - Aug 5/26
Artificial cells reveal how living cells take shape through giant blebs - Aug 5/26
Virus-like particles deliver gene-editing tools into Duchenne mouse model - Aug 4/26
How CRISPR-edited donor islet cells are opening a path toward a functional cure for type 1 diabetes - Aug 4/26
How transposable elements adapt in clinically important adult stem cells - Aug 4/26
AI framework aids target discovery for CAR T cell therapy - Aug 3/26
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness - Aug 3/26
Biogen’s Salanersen shows potential to address unmet needs in spinal muscular atrophy - Aug 3/26
This Week’s CGT News: Gene-Editing Trial Death Raises Concerns - Aug 3/26
Researchers identify immune “off switch” exploited by cancer cells - Aug 2/26
Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration - Jul 30/26
FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Jul 30/26
The next phase of diabetes cell therapy and islet transplantation - Jul 30/26
J&J secures right to take the helm in up to $925M Sail CAR T pact - Jul 30/26
Musings from The Power List: Claudia Zylberberg - Jul 30/26
Scientists at UMass Chan Medical School develop microRNA-based gene therapy that halts ALS progression in mice - Jul 29/26
Teen walks independently after treatment targets the genetic root of epilepsy - Jul 29/26
Donor cord blood composition may influence CAR NK cell therapy outcomes - Jul 29/26
The BioPharm Brief: Designations, Decisions, and Data - Jul 28/26
Phenotypic and functional characterization of CAR-T cells to support robust cell therapy research - Jul 28/26
Leadership changes afoot at two CGT biotechs - Jul 28/26
Blood must flow: How pushing and pulling forces shape our blood vessels - Jul 27/26
Relapsed or refractory multiple myeloma: Early-phase trial investigates novel bispecific antibody - Jul 27/26
This Week’s CGT News: Off-the-shelf CAR T tackles kidney cancer - Jul 26/26
Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, that peptide committee - Jul 26/26
HMN 2026: How sound waves guide cultured cells to form vessel-like networks within one week - Jul 24/26
Mass-producible immune cells kill patient-derived colorectal tumours in mice - Jul 23/26
Four takeaways from our investigation into a hidden gene-editing death - Jul 21/26
Canada has the science. Does it have the strategy to be a life sciences power? - Jul 21/26
Stem cell therapy for GA shows early evidence of vision gains, retina preservation - Jul 21/26
Personalized gene therapy helps teen with rare form of severe epilepsy walk independently - Jul 20/26
This Week’s CGT News: First-in-human diabetes cell therapy - Jul 20/26
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial - Jul 20/26
Scalable cell therapy manufacturing: Shifting from research to GMP
- Sep 13/26
-
